TARO logo

TARO Cash From Investing

Annual CFI

$84.34 M
+$209.90 M+167.18%

March 31, 2024

Summary

Performance

1-Year Change

+167.18%

3-Year Change

+24.51%

5-Year Change

-67.2%

15-Year Change

+171.61%

TARO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$257.14 M
TARO annual cash flow from investing activities is currently -67.20% below its historical high of $257.14 million

3-Year Low

-$170.58 M

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2024
TARO previous annual earnings announcement was published on Mar 31, 2024

Next Annual Earnings Report Date

N/A
TARO next annual earnings announcement has not yet been scheduled

OtherTAROcash flowmetrics:

Annual CFF

-
TARO annual cash flow from financing activities value is unknown

Annual CFO

$124.56 M
TARO annual cash flow from operations is $124.56 million

Annual FCF

$70.34 M
TARO annual free cash flow is $70.34 million

Annual CAPEX

$54.22 M
TARO annual capital expenditures is $54.22 million

Quarterly CFI

-$57.20 M
-$138.87 M-170.03%

March 31, 2024

Summary

Performance

3-Month Change

-170.03%

1-Year Change

-170.03%

3-Year Change

-360.62%

5-Year Change

+53.73%

TARO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$174.84 M
TARO quarterly cash flow from investing activities is currently -132.71% below its historical high of $174.84 million

3-Year Low

-$108.61 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
TARO previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
TARO next earnings announcement has not yet been scheduled

OtherTAROcash flowmetrics:

Quarterly CFF

-
TARO quarterly cash flow from financing activities value is unknown

Quarterly CFO

$38.34 M
TARO quarterly cash flow from operations is $38.34 million

Quarterly FCF

$32.45 M
TARO quarterly free cash flow is $32.45 million

Quarterly CAPEX

$5.89 M
TARO quarterly capital expenditures is $5.89 million

TTM CFI

$84.34 M
-$63.87 M-43.09%

March 31, 2024

Summary

Performance

3-Month Change

-43.09%

1-Year Change

-43.09%

3-Year Change

+24.51%

5-Year Change

+128.56%

TARO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$261.40 M
TARO TTM cash flow from investing activities is currently -67.73% below its historical high of $261.40 million

3-Year Low

-$240.84 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
TARO previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
TARO next earnings announcement has not yet been scheduled

OtherTAROcash flowmetrics:

TTM CFF

-
TARO TTM cash flow from financing activities value is unknown

TTM CFO

$124.56 M
TARO TTM cash flow from operations is $124.56 million

TTM FCF

$70.34 M
TARO TTM free cash flow is $70.34 million

TTM CAPEX

$54.22 M
TARO TTM capital expenditures is $54.22 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TARO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+167.2%-170.0%-43.1%
3 y3 years+24.5%-360.6%+24.5%
5 y5 years-67.2%+53.7%+128.6%

TARO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-302.2%-158.0%+89.9%-43.1%-385.5%
5 y5-year-67.2%-453.5%-158.0%+116.1%-43.1%-487.8%
alltimeall time-67.2%-453.5%-132.7%+310.5%-67.7%-487.8%

Taro Pharmaceutical Industries Cash From Investing History

DateAnnualQuarterlyTTM
Mar 2024
$84.34 M(-167.2%)
-$57.20 M(-170.0%)
$84.34 M(-43.1%)
Dec 2023
-
$81.67 M(-17.1%)
$148.21 M(-599.9%)
Sep 2023
-
$98.57 M(-354.7%)
-$29.65 M(-85.1%)
Jun 2023
-
-$38.70 M(-679.9%)
-$199.01 M(+58.5%)
Mar 2023
-$125.56 M(-26.4%)
$6.67 M(-106.9%)
-$125.56 M(-47.9%)
Dec 2022
-
-$96.19 M(+35.9%)
-$240.84 M(+51.8%)
Sep 2022
-
-$70.79 M(-303.7%)
-$158.67 M(+32.9%)
Jun 2022
-
$34.76 M(-132.0%)
-$119.40 M(-30.0%)
Mar 2022
-$170.58 M(-351.8%)
-$108.61 M(+674.5%)
-$170.58 M(+326.1%)
Dec 2021
-
-$14.02 M(-55.5%)
-$40.03 M(+207.8%)
Sep 2021
-
-$31.53 M(+91.9%)
-$13.00 M(-113.4%)
Jun 2021
-
-$16.43 M(-174.9%)
$97.33 M(+43.7%)
Mar 2021
$67.74 M(-122.7%)
$21.95 M(+68.8%)
$67.74 M(+4766.5%)
Dec 2020
-
$13.00 M(-83.5%)
$1.39 M(-101.0%)
Sep 2020
-
$78.81 M(-271.3%)
-$135.23 M(-58.7%)
Jun 2020
-
-$46.02 M(+3.6%)
-$327.11 M(+9.7%)
Mar 2020
-$298.16 M(-216.0%)
-$44.40 M(-64.1%)
-$298.16 M(+0.9%)
Dec 2019
-
-$123.62 M(+9.3%)
-$295.36 M(-9640.0%)
Sep 2019
-
-$113.07 M(+562.4%)
$3.10 M(-98.7%)
Jun 2019
-
-$17.07 M(-59.0%)
$231.80 M(-9.9%)
Mar 2019
$257.14 M(-206.4%)
-$41.60 M(-123.8%)
$257.14 M(-1.6%)
Dec 2018
-
$174.84 M(+51.2%)
$261.40 M(+227.4%)
Sep 2018
-
$115.64 M(+1299.4%)
$79.84 M(+5498.6%)
Jun 2018
-
$8.26 M(-122.1%)
$1.43 M(-100.6%)
Mar 2018
-$241.64 M(+105.2%)
-$37.33 M(+454.5%)
-$241.64 M(-1.8%)
Dec 2017
-
-$6.73 M(-118.1%)
-$246.00 M(+61.1%)
Sep 2017
-
$37.23 M(-115.9%)
-$152.73 M(-47.5%)
Jun 2017
-
-$234.80 M(+463.2%)
-$290.71 M(+146.8%)
Mar 2017
-$117.78 M(-58.6%)
-$41.69 M(-148.2%)
-$117.78 M(-32.0%)
Dec 2016
-
$86.54 M(-185.9%)
-$173.19 M(-47.1%)
Sep 2016
-
-$100.76 M(+62.9%)
-$327.09 M(+41.0%)
Jun 2016
-
-$61.86 M(-36.3%)
-$232.05 M(-18.5%)
Mar 2016
-$284.73 M(+209.2%)
-$97.10 M(+44.1%)
-$284.73 M(+63.0%)
Dec 2015
-
-$67.36 M(+1077.1%)
-$174.68 M(+4.3%)
Sep 2015
-
-$5.72 M(-95.0%)
-$167.41 M(-39.3%)
Jun 2015
-
-$114.55 M(-984.2%)
-$276.02 M(+199.8%)
Mar 2015
-$92.08 M
$12.96 M(-121.6%)
-$92.08 M(-49.7%)
Dec 2014
-
-$60.10 M(-47.4%)
-$183.01 M(+5.9%)
DateAnnualQuarterlyTTM
Sep 2014
-
-$114.33 M(-264.8%)
-$172.87 M(+116.9%)
Jun 2014
-
$69.39 M(-189.0%)
-$79.68 M(-54.0%)
Mar 2014
-$173.30 M(-29.0%)
-$77.97 M(+56.1%)
-$173.30 M(-17.1%)
Dec 2013
-
-$49.95 M(+136.3%)
-$208.95 M(-17.0%)
Sep 2013
-
-$21.14 M(-12.7%)
-$251.63 M(+25.8%)
Jun 2013
-
-$24.23 M(-78.7%)
-$200.04 M(-18.0%)
Mar 2013
-$243.93 M(-1665.1%)
-$113.63 M(+22.7%)
-$243.93 M(+87.2%)
Dec 2012
-
-$92.63 M(-404.2%)
-$130.30 M(+28.0%)
Sep 2012
-
$30.45 M(-144.7%)
-$101.81 M(-25.4%)
Jun 2012
-
-$68.12 M(+6.2%)
-$136.49 M(+69.9%)
Mar 2012
$15.59 M(-119.4%)
-
-
Dec 2011
-$80.33 M(+234.6%)
-$64.14 M(+1414.1%)
-$80.33 M(<-9900.0%)
Sep 2011
-
-$4.24 M(+338.5%)
$791.00 K(-106.0%)
Jun 2011
-
-$966.00 K(-91.2%)
-$13.09 M(-43.9%)
Mar 2011
-
-$10.99 M(-164.7%)
-$23.31 M(-2.9%)
Dec 2010
-$24.01 M(+78.5%)
$16.98 M(-193.8%)
-$24.01 M(-41.4%)
Sep 2010
-
-$18.11 M(+61.9%)
-$41.00 M(+79.2%)
Jun 2010
-
-$11.19 M(-4.3%)
-$22.88 M(+95.7%)
Mar 2010
-
-$11.69 M
-$11.69 M
Dec 2009
-$13.45 M(-33.7%)
-
-
Dec 2008
-$20.28 M(-599.2%)
-
-
Dec 2007
$4.06 M(-351.4%)
-
-
Dec 2006
-$1.62 M(-95.5%)
-
-
Dec 2005
-$36.22 M(-71.7%)
-
-
Dec 2004
-$127.87 M(+21.9%)
-
-
Dec 2003
-$104.89 M(+110.3%)
-
-
Dec 2002
-$49.87 M(+139.8%)
-
-
Dec 2001
-$20.80 M(+51.6%)
-
-
Dec 2000
-$13.72 M(+54.9%)
-
-
Dec 1999
-$8.86 M(+50.2%)
-
-
Dec 1998
-$5.90 M(-34.4%)
-
-
Dec 1997
-$9.00 M(+2.3%)
-
-
Dec 1996
-$8.80 M(+63.0%)
-
-
Dec 1995
-$5.40 M(+54.3%)
-
-
Dec 1994
-$3.50 M(-28.6%)
-
-
Dec 1993
-$4.90 M(-41.7%)
-
-
Dec 1992
-$8.40 M(+200.0%)
-
-
Dec 1991
-$2.80 M
-
-

FAQ

  • What is Taro Pharmaceutical Industries annual cash flow from investing activities?
  • What is the all time high annual CFI for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries annual CFI year-on-year change?
  • What is Taro Pharmaceutical Industries quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries quarterly CFI year-on-year change?
  • What is Taro Pharmaceutical Industries TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries TTM CFI year-on-year change?

What is Taro Pharmaceutical Industries annual cash flow from investing activities?

The current annual CFI of TARO is $84.34 M

What is the all time high annual CFI for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high annual cash flow from investing activities is $257.14 M

What is Taro Pharmaceutical Industries annual CFI year-on-year change?

Over the past year, TARO annual cash flow from investing activities has changed by +$209.90 M (+167.18%)

What is Taro Pharmaceutical Industries quarterly cash flow from investing activities?

The current quarterly CFI of TARO is -$57.20 M

What is the all time high quarterly CFI for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high quarterly cash flow from investing activities is $174.84 M

What is Taro Pharmaceutical Industries quarterly CFI year-on-year change?

Over the past year, TARO quarterly cash flow from investing activities has changed by -$138.87 M (-170.03%)

What is Taro Pharmaceutical Industries TTM cash flow from investing activities?

The current TTM CFI of TARO is $84.34 M

What is the all time high TTM CFI for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high TTM cash flow from investing activities is $261.40 M

What is Taro Pharmaceutical Industries TTM CFI year-on-year change?

Over the past year, TARO TTM cash flow from investing activities has changed by -$63.87 M (-43.09%)